ieso provides an AI-powered assessment tool and DTx for treating mental health conditions such as depression and anxiety. The platform, offering text-based therapy, is available to nearly 20 million individuals through its network of more than 600 therapists, partnering with healthcare organizations, including the UK National Health Service (NHS) as of November 2021. ieso’s DTx is built on more than 460,000 hours of therapy-related data and has treated over 86,000 individuals.
In November 2021, the company raised GBP 39 million (USD 53 million) in a Series B funding round to develop autonomous text therapy systems and expand its geographic footprint into the US. ieso also plans to seek regulatory approval for its tools across the US and UK, as well as grow its team to 200 by 2022.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.